Achillion pharmaceuticals inc (ACHN)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue

-

0

0

-

-

0

0

-

15,000

15,000

15,000

15,000

31,591

65,411

66,122

66,122

0

0

0

-

-

-

0

-

118

118

118

2,607

2,551

2,615

2,671

247

355

478

0

0

0

Operating expenses
Research and development

57,946

55,795

50,886

50,118

52,153

54,931

62,161

63,607

62,078

63,159

59,060

56,843

53,775

49,057

54,675

56,553

63,337

63,424

55,829

53,515

47,196

46,468

50,859

46,736

45,066

46,365

38,776

38,999

40,499

36,473

36,390

35,441

31,161

27,360

0

0

0

General and administrative

22,297

20,683

23,037

23,896

28,041

28,437

26,337

25,969

23,433

23,438

23,230

23,022

20,893

20,901

25,873

24,676

24,461

23,299

16,761

15,911

14,064

13,104

13,060

12,741

12,288

12,201

11,236

10,901

10,538

9,813

9,669

9,153

8,271

8,039

0

0

0

Restructuring charges (Note 4)

655

730

805

1,900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

80,898

77,208

74,728

75,914

82,094

85,193

90,248

89,576

85,511

86,597

82,290

79,865

74,668

69,958

80,548

81,229

87,798

86,723

72,590

69,426

61,260

59,572

63,919

59,477

57,354

58,566

50,012

49,900

51,037

46,286

46,059

44,594

39,432

35,399

0

0

0

Loss from operations

-80,898

-77,208

-74,728

-75,914

-82,094

-85,193

-90,248

-89,576

-70,511

-71,597

-67,290

-64,865

-43,077

-4,547

-14,426

-15,107

-53,267

-86,012

-72,590

-69,426

-61,260

-59,572

-63,919

-59,477

-57,236

-58,448

-49,894

-47,293

-48,486

-43,671

-43,388

-44,347

-39,077

-34,921

0

0

0

Other income (expense)
Interest income

6,360

6,371

6,120

5,678

5,257

4,906

4,621

4,390

4,100

3,813

3,556

3,227

2,818

2,318

1,715

1,188

802

557

449

455

530

595

663

582

0

0

0

-

-

-

-

-

-

-

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

Interest expense

31

33

35

36

37

41

45

50

51

70

70

68

66

51

54

55

57

49

42

37

32

37

41

52

58

65

76

68

63

56

37

45

102

175

0

0

0

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-74,569

-70,870

-68,643

-70,272

-76,874

-80,328

-85,672

-85,236

-66,462

-67,854

-63,804

-61,706

-40,325

6,664

-3,821

-5,030

-43,578

-85,504

-72,183

-69,008

-60,762

-59,014

-63,297

-58,947

-56,801

-58,137

-49,724

-47,127

-48,308

-43,491

-43,214

-44,206

-39,038

-34,984

0

0

0

Basic and diluted net loss per share (Note 5)

-0.14

-0.14

-0.14

-0.12

-0.12

-0.12

-0.15

-0.17

-0.14

-0.16

-0.15

-0.03

-0.15

-0.14

-0.13

-

-

-0.25

-0.17

-

-

-0.16

-0.17

-0.14

-0.14

-0.21

-0.14

-0.15

-0.20

-0.16

-0.13

-0.18

-0.15

-0.19

-0.17

-0.15

-0.17

Total comprehensive loss (Note 9)

-74,138

-70,158

-67,837

-70,082

-77,019

-80,627

-86,374

-85,776

-66,835

-68,285

-64,052

-61,510

-39,941

7,007

-3,604

-5,063

-43,645

-85,561

-72,159

-69,026

-60,777

-58,847

-63,242

-58,960

-56,838

-58,291

-49,783

-47,088

-48,220

-43,483

-43,186

-44,228

0

0

0

-

-

Weighted average number of shares used in computing basic and diluted net loss per share

139,589

138,761

138,716

138,646

138,586

138,426

138,014

137,887

137,375

136,736

136,722

136,667

136,681

136,680

136,640

-

-

117,770

111,202

-

-

97,017

96,792

96,854

96,648

96,580

85,850

79,591

74,647

71,211

70,411

-

69,725

58,938

-

-

-

Basic net income (loss) per share (Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.19

-

-

-

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per share (Note 5)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.19

-

-

-

-0.16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

136,439

-

-

-

99,031

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

140,024

-

-

-

99,031

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47,576

38,540